Janux Therapeutics
JANX
JANX
49 hedge funds and large institutions have $388M invested in Janux Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
49
Holding in Top 10
1
Calls
$2K
Puts
–
Top Buyers
1 | +$24.3M | |
2 | +$5.71M | |
3 | +$1.54M | |
4 |
Morgan Stanley
New York
|
+$1.54M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.5M |
Top Sellers
1 | -$658K | |
2 | -$609K | |
3 | -$141K | |
4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$27K |
5 |
Goldman Sachs
New York
|
-$24.6K |